MIF-1 is a tripeptide containing aromatic and hydrophobic residues arranged to influence local conformational stability. The motif supports studies of peptide-protein interactions, solvent-induced folding, and enzymatic processing. Researchers use it to explore compact structural states and residue-dependent binding. Its short length enables high-resolution analytical characterization.
CAT No: R2092
CAS No:2002-44-0
Synonyms/Alias:H-Pro-Leu-Gly-NH2;Melanocyte-Stimulating Hormone Release-Inhibiting Factor;Melanocyte-Stimulating Hormone Release-Inhibiting Hormone;Melanostatin;MIF-1;MIF-I;MSH Release-Inhibiting Factor;MSH Release-Inhibiting Hormone;Oxytocin (7-9);Pro-Leu-Gly-NH2;Pro-Leu-Glyamide;Prol Leu Gly NH2;Prol-Leu-Gly-NH2;Prolyl Leucyl Glycinamide;Prolyl-Leucyl-Glycinamide;Prolylleucylglycinamide
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.